Next Article in Journal
Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
Next Article in Special Issue
Treatment of Major Depressive Disorder in Pediatric Populations
Previous Article in Journal
Viral Vectors in Gene Therapy
Previous Article in Special Issue
Revisiting CD28 Superagonist TGN1412 as Potential Therapeutic for Pediatric B Cell Leukemia: A Review
Review

Zebrafish Models of Rare Hereditary Pediatric Diseases

1
Department of Genetics, ELTE Eötvös Loránd University, 1117 Budapest, Hungary
2
MTA-SE Lendület Nephrogenetic Laboratory, 1083 Budapest, Hungary
3
Ist Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary
*
Authors to whom correspondence should be addressed.
Diseases 2018, 6(2), 43; https://doi.org/10.3390/diseases6020043
Received: 27 April 2018 / Revised: 17 May 2018 / Accepted: 19 May 2018 / Published: 22 May 2018
(This article belongs to the Special Issue Pediatric Diseases)
Recent advances in sequencing technologies have made it significantly easier to find the genetic roots of rare hereditary pediatric diseases. These novel methods are not panaceas, however, and they often give ambiguous results, highlighting multiple possible causative mutations in affected patients. Furthermore, even when the mapping results are unambiguous, the affected gene might be of unknown function. In these cases, understanding how a particular genotype can result in a phenotype also needs carefully designed experimental work. Model organism genetics can offer a straightforward experimental setup for hypothesis testing. Containing orthologs for over 80% of the genes involved in human diseases, zebrafish (Danio rerio) has emerged as one of the top disease models over the past decade. A plethora of genetic tools makes it easy to create mutations in almost any gene of the zebrafish genome and these mutant strains can be used in high-throughput preclinical screens for active molecules. As this small vertebrate species offers several other advantages as well, its popularity in biomedical research is bound to increase, with “aquarium to bedside” drug development pipelines taking a more prevalent role in the near future. View Full-Text
Keywords: zebrafish; rare disease models; drug screening zebrafish; rare disease models; drug screening
Show Figures

Figure 1

MDPI and ACS Style

Varga, M.; Ralbovszki, D.; Balogh, E.; Hamar, R.; Keszthelyi, M.; Tory, K. Zebrafish Models of Rare Hereditary Pediatric Diseases. Diseases 2018, 6, 43. https://doi.org/10.3390/diseases6020043

AMA Style

Varga M, Ralbovszki D, Balogh E, Hamar R, Keszthelyi M, Tory K. Zebrafish Models of Rare Hereditary Pediatric Diseases. Diseases. 2018; 6(2):43. https://doi.org/10.3390/diseases6020043

Chicago/Turabian Style

Varga, Máté, Dorottya Ralbovszki, Eszter Balogh, Renáta Hamar, Magdolna Keszthelyi, and Kálmán Tory. 2018. "Zebrafish Models of Rare Hereditary Pediatric Diseases" Diseases 6, no. 2: 43. https://doi.org/10.3390/diseases6020043

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop